374 related articles for article (PubMed ID: 32767977)
1. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis.
Ji Y; Wang H
World J Surg Oncol; 2020 Aug; 18(1):197. PubMed ID: 32767977
[TBL] [Abstract][Full Text] [Related]
2. The role of preoperative systemic immune-inflammation index in predicting the prognosis of patients with digestive tract cancers: A meta-analysis.
Gao H; Wusiman L; Cao BW; Wujieke A; Zhang WB
Transpl Immunol; 2022 Aug; 73():101613. PubMed ID: 35500845
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic cancer: a meta-analysis of 2,365 patients.
Shui Y; Li M; Su J; Chen M; Gu X; Guo W
Aging (Albany NY); 2021 Aug; 13(16):20585-20597. PubMed ID: 34435973
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis.
Zhang Y; Sun Y; Zhang Q
Cancer Cell Int; 2020; 20():224. PubMed ID: 32528232
[TBL] [Abstract][Full Text] [Related]
5. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis.
Zhang C; Yang Q
Front Oncol; 2020; 10():572203. PubMed ID: 33634012
[TBL] [Abstract][Full Text] [Related]
6. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: a meta-analysis.
Wang Q; Zhu SR; Huang XP; Liu XQ; Liu JB; Tian G
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1302-1310. PubMed ID: 33629300
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of systemic immune-inflammation index in patients with pancreatic cancer: a meta-analysis.
Li M; Li Z; Wang Z; Yue C; Hu W; Lu H
Clin Exp Med; 2022 Nov; 22(4):637-646. PubMed ID: 35022918
[TBL] [Abstract][Full Text] [Related]
9. Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis.
Li X; Gu L; Chen Y; Chong Y; Wang X; Guo P; He D
Ann Med; 2021 Dec; 53(1):1827-1838. PubMed ID: 34647517
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of systemic immune-inflammation index in patients with ovarian cancer: a meta-analysis.
Mao H; Yang F
Front Oncol; 2023; 13():1193962. PubMed ID: 37342198
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis.
Meng L; Yang Y; Hu X; Zhang R; Li X
J Transl Med; 2023 Feb; 21(1):79. PubMed ID: 36739407
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of the systemic immune-inflammation index and pan-immune inflammation value for outcomes of breast cancer: a systematic review and meta-analysis.
Cheng HW; Wang T; Yu GC; Xie LY; Shi B
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(1):180-190. PubMed ID: 38235869
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis.
Wang Y; Li Y; Chen P; Xu W; Wu Y; Che G
Ann Transl Med; 2019 Sep; 7(18):433. PubMed ID: 31700869
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of the systemic immune-inflammation index in biliary tract cancers: a meta-analysis of 3,515 patients.
Zhang B; Yao W
World J Surg Oncol; 2022 Sep; 20(1):320. PubMed ID: 36171621
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of systemic immune-inflammation index in patients with nasopharyngeal carcinoma: a meta-analysis.
Zeng Z; Xu S; Wang D; Qin G
Syst Rev; 2022 Nov; 11(1):247. PubMed ID: 36403072
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis.
Huang Y; Gao Y; Wu Y; Lin H
Cancer Cell Int; 2020; 20():499. PubMed ID: 33061851
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer.
Liu J; Shi Z; Bai Y; Liu L; Cheng K
Cancer Manag Res; 2019; 11():4471-4480. PubMed ID: 31191009
[No Abstract] [Full Text] [Related]
18. Prognostic significance of the systemic immune-inflammation index in pancreatic carcinoma patients: a meta-analysis.
Li X; Lin H; Ouyang R; Yang Y; Peng J
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34286342
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of pretreatment systemic immune-inflammation index in patients with prostate cancer: a meta-analysis.
Zhang B; Xu T
World J Surg Oncol; 2023 Jan; 21(1):2. PubMed ID: 36600256
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of systemic immune-inflammation index in surgical esophageal cancer patients: An updated meta-analysis.
Li X; Zhang S; Lu J; Li C; Li N
Front Surg; 2022; 9():922595. PubMed ID: 36090319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]